Pacific Edge Limited (PEB.AX)
AUD 0.08
(0.0%)
AUD 0.08
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 4.44 Million NZD | 263.36% |
| 2023 | 1.22 Million NZD | -36.45% |
| 2022 | 1.92 Million NZD | -33.18% |
| 2021 | 2.87 Million NZD | 85.2% |
| 2020 | 1.55 Million NZD | 1750.0% |
| 2019 | 84 Thousand NZD | -15.15% |
| 2018 | 99 Thousand NZD | 0.0% |
| 2017 | - NZD | 0.0% |
| 2016 | - NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| 2014 | - NZD | -100.0% |
| 2013 | 152.5 Thousand NZD | -20.0% |
| 2012 | 190.62 Thousand NZD | 0.0% |
| 2011 | 190.62 Thousand NZD | 0.0% |
| 2010 | 190.62 Thousand NZD | 0.0% |
| 2009 | 190.62 Thousand NZD | -37.22% |
| 2008 | 303.62 Thousand NZD | 2936.25% |
| 2007 | 10 Thousand NZD | -87.24% |
| 2006 | 78.35 Thousand NZD | -16.37% |
| 2005 | 93.68 Thousand NZD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 884 Thousand NZD | 0.0% |
| 2024 Q3 | 2.8 Million NZD | 217.76% |
| 2024 Q4 | 4.44 Million NZD | 58.07% |
| 2024 Q1 | 884 Thousand NZD | -27.66% |
| 2024 FY | 4.44 Million NZD | 263.36% |
| 2023 Q2 | 664 Thousand NZD | 0.0% |
| 2023 Q4 | 1.22 Million NZD | 197.32% |
| 2023 FY | 1.22 Million NZD | -36.45% |
| 2023 Q3 | 411 Thousand NZD | -38.1% |
| 2023 Q1 | 664 Thousand NZD | -65.47% |
| 2022 Q3 | 851 Thousand NZD | -35.29% |
| 2022 Q4 | 1.92 Million NZD | 125.97% |
| 2022 FY | 1.92 Million NZD | -33.18% |
| 2022 Q1 | 1.31 Million NZD | -54.31% |
| 2022 Q2 | 1.31 Million NZD | 0.0% |
| 2021 FY | 2.87 Million NZD | 85.2% |
| 2021 Q2 | 3.11 Million NZD | 0.0% |
| 2021 Q1 | 3.11 Million NZD | 100.45% |
| 2021 Q4 | 2.87 Million NZD | 61.69% |
| 2021 Q3 | 1.78 Million NZD | -42.86% |
| 2020 Q1 | 352 Thousand NZD | 319.05% |
| 2020 Q4 | 1.55 Million NZD | 172.15% |
| 2020 Q2 | 352 Thousand NZD | 0.0% |
| 2020 Q3 | 571 Thousand NZD | 62.22% |
| 2020 FY | 1.55 Million NZD | 1750.0% |
| 2019 Q1 | 48 Thousand NZD | -51.52% |
| 2019 FY | 84 Thousand NZD | -15.15% |
| 2019 Q4 | 84 Thousand NZD | 162.5% |
| 2019 Q3 | 32 Thousand NZD | -33.33% |
| 2019 Q2 | 48 Thousand NZD | 0.0% |
| 2018 Q1 | 54 Thousand NZD | 0.0% |
| 2018 FY | 99 Thousand NZD | 0.0% |
| 2018 Q4 | 99 Thousand NZD | 280.77% |
| 2018 Q3 | 26 Thousand NZD | -51.85% |
| 2018 Q2 | 54 Thousand NZD | 0.0% |
| 2017 Q1 | - NZD | 0.0% |
| 2017 FY | - NZD | 0.0% |
| 2017 Q4 | - NZD | 0.0% |
| 2017 Q3 | - NZD | 0.0% |
| 2017 Q2 | - NZD | 0.0% |
| 2016 Q3 | - NZD | 0.0% |
| 2016 Q4 | - NZD | 0.0% |
| 2016 FY | - NZD | 0.0% |
| 2016 Q1 | - NZD | 0.0% |
| 2016 Q2 | - NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2015 Q4 | - NZD | 0.0% |
| 2015 Q3 | - NZD | 0.0% |
| 2015 Q2 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 FY | - NZD | -100.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| 2014 Q1 | - NZD | -100.0% |
| 2013 Q3 | - NZD | 0.0% |
| 2013 FY | 152.5 Thousand NZD | -20.0% |
| 2013 Q4 | 152.5 Thousand NZD | 0.0% |
| 2012 Q4 | 190.62 Thousand NZD | 0.0% |
| 2012 FY | 190.62 Thousand NZD | 0.0% |
| 2011 FY | 190.62 Thousand NZD | 0.0% |
| 2011 Q4 | 190.62 Thousand NZD | 0.0% |
| 2010 FY | 190.62 Thousand NZD | 0.0% |
| 2010 Q4 | 190.62 Thousand NZD | 0.0% |
| 2009 Q4 | 190.62 Thousand NZD | 0.0% |
| 2009 FY | 190.62 Thousand NZD | -37.22% |
| 2008 FY | 303.62 Thousand NZD | 2936.25% |
| 2008 Q4 | 303.62 Thousand NZD | 0.0% |
| 2007 FY | 10 Thousand NZD | -87.24% |
| 2006 FY | 78.35 Thousand NZD | -16.37% |
| 2005 FY | 93.68 Thousand NZD | 0.0% |
| 2005 Q4 | 93.68 Thousand NZD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 308.89 Million AUD | 98.563% |
| BCAL Diagnostics Limited | 641.34 Thousand AUD | -592.332% |
| Genetic Signatures Limited | 1.22 Million AUD | -263.653% |
| Genetic Technologies Limited | 643.54 Thousand AUD | -589.959% |
| Healius Limited | 1.59 Billion AUD | 99.722% |
| Imagion Biosystems Limited | 6.03 Million AUD | 26.467% |
| Integral Diagnostics Limited | 357.79 Million AUD | 98.759% |
| INOVIQ Ltd | 535.05 Thousand AUD | -729.853% |
| Microba Life Sciences Limited | 395.38 Thousand AUD | -1023.002% |
| Monash IVF Group Limited | 59.56 Million AUD | 92.546% |
| Rhythm Biosciences Limited | 163.82 Thousand AUD | -2610.383% |
| Sonic Healthcare Limited | 4.51 Billion AUD | 99.902% |